Product

Company

NCT01734668·17 sites·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Quidel Corporation

Age

0–18

Sex

ALL

Healthy volunteers

Not accepted

1. Male or Female
2. Children less than nineteen (19) years of age can participate (assuming appropriate consent is obtained).
3. Must currently be exhibiting symptoms characteristic of respiratory syncytial virus (RSV) illness.
4. Subjects must present with one or more of the following to be eligible for enrollment:
* Fever, ≥ 37.8º C (100º F) at present or within past 24 hours
* Moderate to severe runny nose\*
* Moderate to severe congestion\*
* Decreased appetite
* Coughing
* Sneezing\*
* Wheezing
* Irritability
* Decreased activity
* Labored breathing

1. Subjects nineteen years of age or older.
2. The parent or legal guardian is unable to understand and consent to participation.
3. Current or prior treatment during this infection with anti-RSV Synagis®.

The record

StatusCompleted

PhaseNo phase

Taking part2,468

StartedMar 2012

UpdatedFeb 7, 2013

Conditions

Where17

Clareo Health | Sofia RSV FIA Field Study